Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, NeuroOne Medical Technologies Corp’s stock clocked out at $0.56, up 4.56% from its previous closing price of $0.54. In other words, the price has increased by $4.56 from its previous closing price. On the day, 0.5 million shares were traded. NMTC stock price reached its highest trading level at $0.5959 during the session, while it also had its lowest trading level at $0.5001.
Ratios:
To gain a deeper understanding of NMTC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 3.58. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on March 29, 2022, Downgraded its rating to Hold and sets its target price to $2 from $6 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 04 ’25 when McClurg Ronald W. bought 200,000 shares for $0.50 per share. The transaction valued at 100,000 led to the insider holds 444,117 shares of the business.
Rosa David A bought 100,000 shares of NMTC for $50,000 on Apr 04 ’25. The CEO and President now owns 1,161,289 shares after completing the transaction at $0.50 per share. On Mar 14 ’25, another insider, Christianson Mark, who serves as the Co-Founder, VP of Business Com of the company, bought 30,000 shares for $1.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMTC now has a Market Capitalization of 26753852 and an Enterprise Value of 16632155. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.06 while its Price-to-Book (P/B) ratio in mrq is 5.93. Its current Enterprise Value per Revenue stands at 2.893 whereas that against EBITDA is -2.546.
Stock Price History:
The Beta on a monthly basis for NMTC is 0.74, which has changed by -0.50438595 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, NMTC has reached a high of $1.39, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -39.33%, while the 200-Day Moving Average is calculated to be -36.17%.
Shares Statistics:
It appears that NMTC traded 270.25K shares on average per day over the past three months and 690510 shares per day over the past ten days. A total of 47.39M shares are outstanding, with a floating share count of 40.49M. Insiders hold about 14.56% of the company’s shares, while institutions hold 19.70% stake in the company. Shares short for NMTC as of 1743379200 were 147830 with a Short Ratio of 0.55, compared to 1740700800 on 204249. Therefore, it implies a Short% of Shares Outstanding of 147830 and a Short% of Float of 0.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
